A specific transcription factor Yin‐Yang 1 (YY1) has been discovered to be coexpressed with KLF4 and to positively regulate the KLF4 expression, suggesting that both YY1 and KLF4 could serve as potential therapeutic biomarkers for NHL [155, 156]. This evidence concerns the gene KLF4 and non-Hodgkin lymphoma.